Table 5B.
Strong RBD-IgG antibody decline for medical personnel (n = 116).
| Risk factor | OR | 95% CI | p-value |
|---|---|---|---|
| Age | 1·065 | [1·006,1·129] | 0·032 |
| Sex (Ref. = female) | 1·204 | [0·299,4.853] | 0·794 |
| Vaccine type (Ref. = mRNA-1273) | 3·320 | [0·921,11·963] | 0·067 |
| BMI | 0·927 | [0·792,1·085] | 0·346 |
Ref. = reference category; a “strong RBD-IgG antibody decline” between T2 (two months after first vaccination) and T3 (six months) was defined as described in Results and in more detail in Supplementary material. Comparator is the MP cohort. IS means immunosuppression; BMI means body mass index.
Model fit: AIC = 80.38; BIC = 93.97